Leerink, Citi and Guggenheim acted as joint book running managers for the offering.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on LRMR:
- Larimar Therapeutics Announces Proposed Underwritten Public Offering
- Larimar Therapeutics price target raised to $25 from $17 at JMP Securities
- Larimar Therapeutics price target raised to $10 from $4.50 at Citi
- Larimar Therapeutics Announces Successful Phase 2 Nomlabofusp Study
- Larimar Therapeutics Reports Positive Phase 2 Results, Updates Investor Resources
